Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02406781
Title Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial (PEMBROSARC)
Acronym PEMBROSARC
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Bergonié
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut Bergonié Bordeaux 33076 France Details
Centre Oscar Lambret Lille 59020 France Details
Centre Léon Bérard Lyon 69373 France Details
Institut Paoli Calmettes Marseille 13273 France Details
Institut Curie Paris 75005 France Details
Institut de Cancérologie de l'Ouest Saint-Herblain 44805 France Details
Institut Claudius Regaud Toulouse 31052 France Details
Institut Gustave Roussy Villejuif 94800 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field